Results 21 to 30 of about 957 (147)

Synthesis and structure−activity relationships of teixobactin [PDF]

open access: yesAnnals of the New York Academy of Sciences, 2019
AbstractThe discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial ...
Karas, JA   +10 more
openaire   +5 more sources

Mode of action of teixobactins in cellular membranes [PDF]

open access: yesNature Communications, 2020
The natural antibiotic teixobactin kills bacteria by direct binding to their cognate cell wall precursors (Lipid II and III). Here authors use solid-state NMR to reveal the native binding mode of teixobactins and show that teixobactins only weakly bind ...
Rhythm Shukla   +14 more
doaj   +7 more sources

Alanine scan reveals modifiable residues in teixobactin [PDF]

open access: yesChemical Communications, 2017
An alanine scan reveals the tolerance of amino acids in teixobactin toward substitution.
K. H. Chen   +4 more
openaire   +6 more sources

Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery [PDF]

open access: yesACS Infectious Diseases, 2017
Increasing bacterial resistance against current antibiotics and lack of new molecules to combat bacterial resistance are key challenges to global health. There is, therefore, a continuing need to develop new antibiotics. Teixobactin, a cyclic undecapeptide, displays excellent antibacterial activities against a range of pathogenic bacteria, such as ...
William D. Fiers   +2 more
core   +5 more sources

Synthesis and Biological Evaluation of a Teixobactin Analogue

open access: yesOrganic Letters, 2015
The first synthesis and biological activity of a teixobactin analogue is reported. Substitution of the unusual L-allo-enduracididine residue by the naturally occurring L-arginine was achieved, and the analogue gave an activity trend similar to that of teixobactin (against Gram-postive bacteria) and meropenem, which was approved by the FDA in 1996.
Yahya E, Jad   +8 more
openaire   +3 more sources

SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF TEIXOBACTIN ANALOGUES [PDF]

open access: yes
Multi-drug resistant bacteria that are primarily unresponsive towards the available marketed antibiotics presents a threat to global health, leading to an increase in mortality and morbidity rate. Today, more than 700,000 people die annually as a consequence to the bacterial infections. This number is expected to rise to 10 million by 2050.
Malkawi, Ruba
openaire   +2 more sources

Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin

open access: yesJournal of Medicinal Chemistry, 2018
Teixobactin, targeting lipid II, represents a new class of antibiotics with novel structures and has excellent activity against Gram-positive pathogens. We developed a new convergent method to synthesize a series of teixobactin analogues and explored structure-activity relationships.
Yu Zong   +5 more
openaire   +3 more sources

Teixobactin, the first of a new class of antibiotics discovered by iChip technology? [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2015
Teixobactin is a recently described antibiotic of a new class produced by a hitherto undescribed soil microorganism (provisionally named Eleftheria terrae). It was isolated with a new tool, the iChip, that allowed the environmental bacterium to grow and for the antibiotic it produced to be isolated and subsequently identified.
Piddock, Laura J V
openaire   +5 more sources

Vancomycin-Teixobactin Conjugates. [PDF]

open access: yesJ Am Chem Soc
Vancomycin continues to be a widely used antibiotic of last resort in treating drug-resistant pathogens despite the emergence of vancomycin-resistant strains such as vancomycin-resistant Enterococci (VRE). This communication reports that conjugation of vancomycin to a second antibiotic that targets a different region of lipid II enhances and rescues ...
Padilla MSTL, Nowick JS.
europepmc   +5 more sources

Antibiotic Resistance in the Elderly: Mechanisms, Risk Factors, and Solutions [PDF]

open access: yesMicroorganisms
Antibiotic resistance presents a critical challenge in healthcare, particularly among the elderly, where multidrug-resistant organisms (MDROs) contribute to increased morbidity, mortality, and healthcare costs.
Nikolaos Theodorakis   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy